CMKLR1 and familial dilated cardiomyopathy: Compared with the DCM+NC group, DCM+CMKLR1-siRNA group exhibited increased EF, FS, and E/A, and decreased LVEDd (Figures 4A–E; p < 0.05∼p < 0.01); however, no differences were observed in SBP or DBP between the two groups (Figure 4F).